Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
Authors:
- 1 June 2021
- journal article
- review article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 361 (6) , 683-689
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A small jab – a big effect: nonspecific immunomodulation by vaccinesTrends in Immunology, 2013
- Nonspecific Effects of Vaccines and the Reduction of Mortality in ChildrenClinical Therapeutics, 2013
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences, 2012
- Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 DiabetesPLOS ONE, 2012
- CD4 T-Cell-Mediated Heterologous Immunity between Mycobacteria and PoxvirusesJournal of Virology, 2009
- Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCGProceedings of the National Academy of Sciences, 2008
- Potential health effects from non‐specific stimulation of the immune function in early age: The example of BCG vaccinationPediatric Allergy and Immunology, 2008
- BCG vaccination scar associated with better childhood survival in Guinea-BissauInternational Journal of Epidemiology, 2005
- BCG scar and positive tuberculin reaction associated with reduced child mortality in West AfricaVaccine, 2003
- STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A METHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG)Journal of Experimental Medicine, 1964